|
⚲
|
| Keyboard |
| KPCB Pandemic & Bio Defense Fund LLC
✚
|
|
|---|---|
| CIK # | 0001356809 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001356809] | |
| 4 | [0001356809] | |
| SC 13G | [0001356809] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| KPCB Pandemic & Bio Defense Fund LLC | Sagimet Biosciences Inc | [2024-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| KPCB PBD Associates LLC | |
| Sagimet Biosciences Inc | |
| KPCB Pandemic & Bio Defense Fund LLC | |
| Trius Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sagimet Biosciences Inc SGMT
Series A Common Stock
|
2023-07-18 | Conversion | 1,860,712 | ||
|
Sagimet Biosciences Inc SGMT
Series A Common Stock
|
2023-07-18 | Other | 38,763 | ||
|
Sagimet Biosciences Inc SGMT
Common Stock
|
2023-07-18 | Other | 38,763 | ||
|
Sagimet Biosciences Inc SGMT
Series B Preferred Stock · derivative
|
2023-07-18 | Conversion | 493,370 | $0.00 | |
|
Sagimet Biosciences Inc SGMT
Series F Preferred Stock · derivative
|
2023-07-18 | Conversion | 20,430,107 | $0.00 | |
|
Sagimet Biosciences Inc SGMT
Series E Preferred Stock · derivative
|
2023-07-18 | Conversion | 103,127,234 | $0.00 | |
|
Sagimet Biosciences Inc SGMT
Series B-1 Preferred Stock · derivative
|
2023-07-18 | Conversion | 8,596,590 | $0.00 | |
|
Sagimet Biosciences Inc SGMT
Series C Preferred Stock · derivative
|
2023-07-18 | Conversion | 8,596,589 | $0.00 | |
|
Sagimet Biosciences Inc SGMT
Series D Preferred Stock · derivative
|
2023-07-18 | Conversion | 6,103,580 | $0.00 | |
|
Sagimet Biosciences Inc SGMT
Series A Preferred Stock · derivative
|
2023-07-18 | Conversion | 539,006 | $0.00 | |
|
Trius Therapeutics Inc TSRX
Common Stock
|
2013-05-10 | Other | 680,850 | $0.00 |